Subcutaneous immunotherapy in patients with eosinophilic esophagitis

Affiliations

¹ Center for Esophageal Diseases and Swallowing, Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
² Division of Allergy and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
³ Center for Esophageal Diseases and Swallowing, Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina. Electronic address: edellon@med.unc.edu.

Benjamin S Robey et al. Ann Allergy Asthma Immunol. 2019 May.

. 2019 May;122(5):532-533.e3.

doi: 10.1016/j.anai.2019.02.022. Epub 2019 Mar 2.

¹ Center for Esophageal Diseases and Swallowing, Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
² Division of Allergy and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
³ Center for Esophageal Diseases and Swallowing, Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina. Electronic address: edellon@med.unc.edu.

No abstract available

References

1. Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras C, Katzka DA. ACG Clinical Guideline: Evidence based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis. Am J Gastroenterol. 2013;108(5):679–692. - PubMed
1. Pesek RD, Rettiganti M, O’Brien E, et al. Effects of allergen sensitization on response to therapy in children with eosinophilic esophagitis. Ann Allergy Asthma Immunol. August 2017;119(2): 177–183. - PMC - PubMed
1. Wolf WA, Jerath MR, Dellon ES. De-novo onset of eosinophilic esophagitis after large volume allergen exposures. J Gastrointestin Liver Dis. June 2013;22(2):205–208. - PMC - PubMed
1. De Swert L, Veereman G, Bublin M, et al. Eosinophilic gastrointestinal disease suggestive of pathogenesis-related class 10 (PR-10) protein allergy resolved after immunotherapy. J Allergy Clin Immunol. February 2013;131(2):600–602 e601–603. - PubMed
1. Ramirez RM, Jacobs RL. Eosinophilic esophagitis treated with immunotherapy to dust mites. J Allergy Clin Immunol. June 10 2013;132(2):503–504. - PubMed